Library — CHDR

Search

Filter

A Phase 1, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a highly selective NaV1.8 inhibitor, in Healthy Male Adults.

Hijma HJH, Siebenga PSP, de Kam MLM, Groeneveld GJGJ

Pain medicine (Malden, Mass.), 2021 Feb

View publication
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders.

Vissers MFJM, Heuberger JAAC, Groeneveld GJ

International journal of molecular sciences, 2021 Feb

View publication
Analgesic drug development: Proof-of-mechanism and proof-of-concept in early phase clinical studies

H.J.Hijma, G.J.Groeneveld

Medicine in drug discovery, 2021 Feb

View publication
Monitoring the recovery time of children after tonsillectomy using commercial activity trackers.

Lambrechtse P, Ziesenitz VC, Atkinson A, Bos EJ, Welzel T, Gilgen Y, Gürtler N, Heuscher S, Cohen AF, van den Anker JN

European journal of pediatrics, 2021 Feb; 180(2):527-533

View publication
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery versus subcutaneous administration: results of a randomized controlled trial.

Jacobse J, Ten Voorde W, Tandon A, Romeijn SG, Grievink HW, van der Maaden K, van Esdonk MJ, Moes DJAR, Loeff F, Bloem K, de Vries A, Rispens T, Wolbink G, de Kam M, Ziagkos D, Moerland M, Jiskoot W, Bouwstra J, Burggraaf J, Schrier L, Rissmann R, Ten Cate R

British journal of clinical pharmacology, 2021 Jan

View publication
Experience in Genetic Counseling for Variants in Parkinson's Disease.

den Heijer JM, van Hilten JJ, Kievit AJA, Bonifati V, Groeneveld GJ

Movement disorders clinical practice, 2021 Jan; 8(1):33-36

View publication
First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M -receptor partial agonist for the treatment of dementias.

Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Prins S, van der Doef TF, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ

British journal of clinical pharmacology, 2020 Dec

View publication
Assessment of risks associated with SARS-CoV-2 experimental human infection studies.

Kuiper VP, Rosendaal FR, Kamerling IMC, Visser LG, Roestenberg M

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020 Nov

View publication
Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy volunteers.

Moerland M, Kales AJ, Broekhuizen K, Nässander U, Nelissen R, de Kam ML, Peeters PAM, Burggraaf J

British journal of clinical pharmacology, 2020 Nov

View publication

«
1
2
...
6
7
8
9
10
11
12
...
85
86
»